On April 6, Reps. Betty McCollum (D-MN) and Rosa DeLauro (D-CT) penned a letter to Food and Drug Administration (FDA) Commissioner Robert Califf to revisit the output and gain levels within the agency's proposed rulemaking on over-the-counter (OTC) hearing aids.
0 Comments
|
RSS Feed
